Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillanceThomas J. Guzzo, S. Bruce Malkowicz, Daniel Canter et al.|Urologic Oncology Seminars and Original Investigations|2011Cited by 38